Genomic & Biopharma News

CDK4/6 inhibition triggers anti-tumour immunity

Nature, 2017-08-16 00:00:00

Mammals divert endogenous genotoxic formaldehyde into one-carbon metabolism

Nature, 2017-08-16 00:00:00

News of Note—Seqirus, Fujifilm and more
Here's other vaccine news of note for this week.
Fierce Pharma, 2017-08-15 22:20:20

Surprise: A short list of TV-ad drug risks is easier to recall, FDA study finds
Ready to say goodbye to the laundry list of risks in pharma TV ads? Don't hold your breath, but one newly published FDA study found shorter risk statements in DTC commercials led to better recognition and recall.
Fierce Pharma, 2017-08-15 21:54:20

NIH herpesvirus study in mice leads to discovery of potential broad-spectrum antiviral
Scientists unexpectedly found that inhibiting EZH2/1 suppressed viral infection.
National Institutes of Health, 2017-08-15 20:00:00

SynteractHCR taps Novella executive Frank Santoro as CMO
Less than a month after welcoming PRA Health Sciences alum Steve Powell as its new CEO, SynteractHCR has tapped Frank Santoro, M.D., most recently Novella Clinical’s CMO, as its CMO. He has more than 30 years of experience in both the CRO and biopharma space, mostly in oncology.
Fierce Biotech, 2017-08-15 18:51:26

Pharma's social status: LinkedIn and FB up, Twitter down, Instagram finally appears
Facebook is the go-to platform for pharma marketers, a new study finds. That's not surprising, considering the social network's mainstream ubiquity and large reach. But it's also because of Facebook's stepped-up efforts to reel in the pharma industry.
Fierce Pharma, 2017-08-15 17:04:48

Opinion: We Need a Replacement for Bealls List
Although the popular blacklist of predatory publishers is gone, the suspect journals they produce are not.
The Scientist, 2017-08-15 17:00:00

'Dark money' and drugs: Ohio pricing activists cry foul over secret donors
Last year, California voters rejected a ballot measure that proposed limiting the state’s drug prices to those paid by the U.S. Department of Veterans Affairs. A similar campaign is heating up in Ohio, recently spawning allegations of “dark money” from the drug industry in politics.
Fierce Pharma, 2017-08-15 16:41:05